Auteurs Muller C, Lacroix-Malgras V, Kluza J, Laine W, Güler Y, Bost F, Boisbrun M, Mazerbourg S, Flament S
Cancer cell international Apr 2024
HSPA8 chaperone complex drives chaperone-mediated autophagy regulation in acute promyelocytic leukemia cell differentiation.Auteurs Rafiq S, Mungure I, Banz Y, Niklaus NJ, Kaufmann T, Müller S, Jacquel A, Robert G, Auberger P, Torbett BE, Muller S, Tschan MP, Humbert M
Pharmacology Apr 2024
Messing with cancer therapy: how the melanoma phenotype predicts checkpoint inhibitor response.Auteurs Meierjohann S, Bertolotto C
Signal transduction and targeted therapy Apr 2024
[When ubiquitination intertwines with cutaneous melanoma: a mechanism to explore].Auteurs Arrighi N, Breda L, Kerdilès T, Meyer C, Prugneau L, Rabatel O, Wagner G, Krossa I, Pisibon C
Medecine sciences : M/S Mar 2024
[PROTAC technology: a promising approach in oncology].Auteurs Azuaga Moreso M, Bertrand C, Duffrene J, Dumont M, Lecouffe A, Muller C, Arrighi N, Onesto C
Medecine sciences : M/S Mar 2024
[Trained immunity : emerging strategies against antibiotic resistance].Auteurs Badin L, Franc C, Gilbert P, Magdeleine JJ, Martin L, Vernaz R, Arrighi N, Garcia-Sanchez JA
Medecine sciences : M/S Mar 2024
Improving nutritional status after allogeneic stem cell transplantation: results of phase 2 ALLONUT clinical trial.Auteurs Estran S, Loschi M, Benachour S, Soldati A, Chiche E, Sammut R, Robert G, Jacquel A, Chibois J, Schneider S, Cluzeau T
Bone marrow transplantation Mar 2024
Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.Auteurs Montemagno C, Jacquel A, Pandiani C, Rastoin O, Dawaliby R, Schmitt T, Bourgoin M, Palenzuela H, Rossi AL, Ambrosetti D, Durivault J, Luciano F, Borchiellini D, Le Du J, Gonçalves LCP, Auberger P, Benhida R, Kinget L, Beuselinck B, Ronco C, Pagès G, Dufies M
Journal of experimental & clinical cancer research : CR Mar 2024
Mechanisms of melanoma aggressiveness with age.Auteurs Bertolotto C
Nature aging Mar 2024
Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment.Auteurs Krug A, Tosolini M, Madji Hounoum B, Fournié JJ, Geiger R, Pecoraro M, Emond P, Gaulard P, Lemonnier F, Ricci JE, Verhoeyen E
Journal of experimental & clinical cancer research : CR Feb 2024